Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children

NCT04147871 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Unspecified business decision/strategic reason

Conditions

Cystinuria

Interventions

DRUG: ADV7103
DRUG: Placebo

Sponsor

Advicenne Pharma